Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma

NCT00699296 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous T-Cell Lymphoma
Leukemia-Lymphoma, Adult T-Cell

Interventions

DRUG: Panobinostat (LBH589)

Sponsor

Novartis Pharmaceuticals